Financial News
Latest News about XPH
Recent news which mentions XPH
Purdue Pharma Bankruptcy Plan Rejected by Supreme Court, Billionaire Sacklers to Face Lawsuits
June 27, 2024
From Benzinga
Finding Opportunity in Unloved Healthcare ETFs
May 31, 2024
From ETF Trends
Organon Beats On Q1, Women's Health Leads the Charge
May 02, 2024
From Benzinga
Eli Lilly’s stock soars toward best day in 23 years after strong earnings, upbeat Mounjaro outlook
August 08, 2023
From MarketWatch
From MarketWatch
FDA approves Reata’s rare disease drug amid questions about changes to the regulatory environment for neuroscience treatments
February 28, 2023
From MarketWatch
From MarketWatch
What investors need to know about Pfizer’s latest downgrade
January 26, 2023
From MarketWatch
Will 2023 be the year that pharma M&A makes a comeback?
January 12, 2023
From MarketWatch
As COVID vaccine and Paxlovid sales decline, analysts want to know what’s next for Pfizer
January 04, 2023
From MarketWatch
From MarketWatch
Is It Too Late to Buy AbbVie Stock?
May 17, 2022
From Motley Fool
7 Pharmaceutical Stocks That Could Make You Rich
January 06, 2022
From InvestorPlace
Is It Too Late to Buy AbbVie Stock?
December 14, 2021
From Motley Fool
The U.S. stock market suffers ugly Black Friday selloff. Here are the biggest losers (and winners)
November 26, 2021
From MarketWatch
Is Now the Time to Ditch Pharma Stocks?
September 21, 2021
From Motley Fool
2 Pharma Stocks You Can Buy and Hold for the Next Decade
September 16, 2021
From Motley Fool
Moderna stock extends rally after price target gets a 77% boost at Morgan Stanley
September 07, 2021
From MarketWatch
3 Pharma Stocks to Buy in August
August 11, 2021
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.